🔗 Permalink

Inventor profile of:

Peter D. Kwong

City:

Washington, District of Columbia

Country:

United States

Published Applications:

35

Last publication date:

2026-05-28

Top Assignees for applications by Peter D. Kwong

The entities that hold a legal rights for patent applications filed by inventor Kwong Peter D.:

The United States of America, as represented by the Secretary, Department of Health and Human Services 8 Bethesda, MD United States
The USA, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Washington, DC United States
UNIVERSITY OF WASHINGTON 3 Seattle, WA United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 3 Bethesda, MD United States
Secretary, Department of Health and Human Services 2 Bethesda, MD United States
The Trustees of Columbia University 2 New York, NY United States
Dana-Farber-Cancer Institute, Inc. 2 Boston, MA United States
The United States of America as represented by the Secretary, Department of Health and Human Services 1 Washingron, DC United States
The Trustees of Columbia University in the City of New York 1 New York, NY United States
The United States of America,as represented by the Secretary,Department of Health and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
UAB Research Foundation, University of Alabama—Birmingham 1 Birmingham, AL United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Methesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 1 Bethesda, MS United States
UAB Research Foundation 1 Birmingham, AL United States
The United State of America, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health 1 Washington, DC United States
The United States of America, as Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
The USA, as represented by the Secretary, Departm- ent of Health and Human Service 1 Bethesda, MD United States
The United States of America,as represented by the Secretary,Department of Helath and Human Services 1 Bethesda, MD United States
The United States of America, as represented by thew Secretary, Department of Health and Human Servi 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 7660 Bethesda, MD United States

Recent patent applications by Kwong Peter D.

Peter D. Kwong from Washington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260146077A1

Chemistry; metallurgy

ENGINEERED SARS-COV-2 ANTIBODIES WITH INCREASED NEUTRALIZATION BREADTH

#2 | 2025-12-04

US20250368690A1

Chemistry; metallurgy

PREFUSION RSV F PROTEINS AND THEIR USE

#3 | 2025-10-23

US20250326823A1

Chemistry; metallurgy

Antigen Binding Polypeptides, Polypeptide Complexes and Methods of Use Thereof

#4 | 2025-06-19

US20250197483A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE

#5 | 2024-09-12

US20240299510A1

Human necessities

ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS

#6 | 2024-08-29

US20240285749A1

Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#7 | 2024-07-04

US20240218055A1

Chemistry; metallurgy

LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE

#8 | 2024-04-11

US20240117011A1

Chemistry; metallurgy

ANTIBODIES TARGETING THE SPIKE PROTEIN OF CORONAVIRUSES

#9 | 2024-01-18

US20240018193A1

Human necessities

Prefusion RSV F proteins and their use

#10 | 2023-10-19

US20230330210A1

Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#11 | 2022-09-29

US20220306735A1

Chemistry; metallurgy

COMPOSITIONS INCLUDING IGG FC MUTATIONS AND USES THEREOF

#12 | 2022-02-03

US20220031834A1

Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#13 | 2022-01-06

US20220002351A1

Chemistry; metallurgy

PREFUSION RSV F PROTEINS AND THEIR USE

#14 | 2019-10-17

US20190314490A1

Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#15 | 2019-01-17

US20190016786A1

Chemistry; metallurgy

Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein

#16 | 2018-11-08

US20180319846A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#17 | 2017-09-21

US20170267748A1

Chemistry; metallurgy

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

#18 | 2017-07-20

US20170202946A1

Human necessities

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#19 | 2016-12-15

US20160362478A1

Chemistry; metallurgy

CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIES

#20 | 2016-02-18

US20160046675A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#21 | 2015-02-12

US20150044137A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

#22 | 2014-11-27

US20140350113A1

Chemistry; metallurgy

CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof

#23 | 2014-10-30

US20140322163A1

Chemistry; metallurgy

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

#24 | 2012-12-13

US20120315270A1

Human necessities

RSV IMMUNOGENS, ANTIBODIES AND COMPOSITIONS THEREOF

#25 | 2012-11-08

US20120282264A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 and their use

#26 | 2012-09-27

US20120244166A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

#27 | 2012-09-20

US20120237523A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 and their use

#28 | 2012-02-09

US20120034254A1

Chemistry; metallurgy

ANTIGENIC CLOAKING AND ITS USE

#29 | 2010-03-18

US20100068217A1

EPITOPE-TRANSPLANT SCAFFOLDS AND THEIR USE

#30 | 2009-09-03

US20090220536A1

Chemistry; metallurgy

Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

#31 | 2009-06-25

US20090162390A1

Human necessities

Molecular scaffolds for HIV-1 immunogens

#32 | 2009-04-30

US20090110690A1

Chemistry; metallurgy

Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens

#33 | 2006-05-11

US20060099572A1

Chemistry; metallurgy

Crystallization reagent matrices and related methods and kits

#34 | 2005-10-06

US20050220817A1

Chemistry; metallurgy

Stabilized soluble glycoprotein trimers

#35 | 2005-05-19

US20050106177A1

Chemistry; metallurgy

Stabilized soluble glycoprotein trimers

InventorID:

952623 ⎘